Skip to content

Management of Diabetes Mellitus Patients With Retinopathy

Management of Diabetes Mellitus Patients With Retinopathy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00828425
Enrollment
2500
Registered
2009-01-26
Start date
2008-12-31
Completion date
2009-08-31
Last updated
2010-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Retinopathy

Keywords

Diabetes Mellitus, retinopathy, Management of diabetic patients with retinopathy

Brief summary

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed: * which medication are used to keep blood pressure under control? * which medication are used for metabolic control? * the average control level of metabolism and blood pressure is compliant with the international guidelines? * laser photocoagulation plays a role in the control of metabolism and blood pressure? * there are differences in the control of metabolism and blood pressure between patients with DM I or DM II? * there is an influence of renal failure on the choose of medication?

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Diabetic patients * Diabetic retinopathy

Design outcomes

Primary

MeasureTime frame
Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weightevery 3 months
evolution of diabetic retinopathyevery 3 months

Secondary

MeasureTime frame
concomitant medicationevery 3 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026